Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Medicure's MC-1 shows good results in ischemia models

March 20, 2000

Georgetown scientists describe mechanism of action of bertosamil

March 17, 2000

Impressive evidence for antiatherosclerotic efficacy of VasoCare therapy presented at ACC

March 17, 2000

More MARISA results reported at ACC meeting by CV Therapeutics and collaborators

March 17, 2000

The FDA grants orphan drug status for Avant's lead complement inhibitor

March 17, 2000

Novel features of H-345/52 indicate promising activity in tachyarrhythmia

March 16, 2000

Continued treatment with Enbrel safe and effective in chronic heart failure

March 16, 2000

New use for teprenone in myocardial preconditioning? Evidence presented at ACC meeting

March 16, 2000

CytRx to continue Flocor development as treatment for sickle cell disease

March 16, 2000

ACC news: preliminary clinical results presented for Chiron's rFGF-2 angiogenesis therapy

March 15, 2000

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...